iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
DEL PRIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionFmr Llc
Latest Disclosed Ownership18,435 shares
Latest Disclosed Value $ 3,112,690
Fmr Llc ownership in 0JGB / iShares Trust - iShares Biotechnology ETF

On May 15, 2026 - Fmr Llc filed a 13F-HR form disclosing ownership of 18,435 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $3,112,690 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 16,011 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 15.14% during the quarter. The current value of the position is $2,415,907 USD.

Fmr Llc has a history of taking positions in derivatives of the underlying security (0JGB) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

GB:0JGB / iShares Trust - iShares Biotechnology ETF Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 18,435 2,424 15.14 3,113 14.92 0.0000
2026-02-17 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 16,011 2,879 21.92 2,709 42.90 0.0001
2025-11-13 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 13,132 443 3.49 1,896 18.07 0.0001
2025-08-14 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 12,689 -2,231 -14.95 1,606 -15.88 0.0001
2025-05-12 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 14,920 189 1.28 1,908 -2.00 0.0001
2025-02-13 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 14,731 281 1.94 1,948 -7.42 0.0001
2024-11-13 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 14,450 2,332 19.24 2,104 26.23 0.0001
2024-08-13 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 12,118 -135 -1.10 1,666 -1.07 0.0001
2024-05-13 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 12,253 2,056 20.16 1,685 21.59 0.0001
2024-02-13 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 10,197 1,306 14.69 1,385 27.41 0.0001
2023-11-13 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 8,891 147 1.68 1,087 -2.07 0.0001
2023-08-11 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 8,744 -555 -5.97 1,110 -7.58 0.0001
2023-08-11 2023-03-31 13F/A-1 ISHARES TR ISHARES BIOTECH 464287556 9,299 -121 -1.28 1,201 -2.83 0.0001
2023-05-11 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 9,299 -121 1,201 0.0000
2023-02-13 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 9,420 63 0.67 1,237 12.98 0.0001
2022-11-10 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 9,357 -882 -8.61 1,094 -9.14 0.0001
2022-08-12 2022-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 10,239 871 9.30 1,204 -1.39 0.0001
2022-05-13 2022-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 9,368 648 7.43 1,221 -8.26 0.0001
2022-02-14 2021-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 8,720 979 12.65 1,331 6.31 0.0001
2022-02-14 2021-09-30 13F/A-1 ISHARES TR ISHARES BIOTECH 464287556 7,741 -1,335 -14.71 1,252 -15.69 0.0001
2021-11-15 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 7,741 -1,335 1,252 0.0000
2021-08-13 2021-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 9,076 -697 -7.13 1,485 0.95 0.0001
2021-05-14 2021-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 9,773 918 10.37 1,471 9.61 0.0001
2021-02-08 2020-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 8,855 -1,191 -11.86 1,342 -1.32 0.0001
2020-11-13 2020-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 10,046 -561 -5.29 1,360 -6.14 0.0001
2020-08-24 2020-06-30 13F/A-1 ISHARES TR NASDAQ BIOTECH 464287556 10,607 608 6.08 1,449 34.42 0.0002
2020-08-13 2020-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 10,607 608 1,449 35.5977
2020-05-14 2020-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 9,999 -69 -0.69 1,078 -11.13 0.0001
2020-02-07 2019-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 10,068 -140 -1.37 1,213 19.51 0.0001
2019-11-13 2019-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 10,208 221 2.21 1,015 -6.80 0.0001
2019-08-13 2019-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 9,987 -441 -4.23 1,089 -6.60 0.0001
2019-05-13 2019-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 10,428 -1,066 -9.27 1,166 5.14 0.0001
2019-02-13 2018-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 11,494 -221 -1.89 1,109 -22.34 0.0002
2018-11-09 2018-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 11,715 -397 -3.28 1,428 7.37 0.0002
2018-08-10 2018-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 12,112 1,297 11.99 1,330 15.25 0.0002
2018-05-14 2018-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 10,815 295 2.80 1,154 2.76 0.0001
2018-02-12 2017-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 10,520 7,249 221.61 1,123 2.93 0.0001
2017-11-13 2017-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 3,271 -9 -0.27 1,091 7.28 0.0001
2017-08-29 2017-06-30 13F/A-1 ISHARES TR NASDQ BIOTEC ETF 464287556 3,280 412 14.37 1,017 20.93 0.0001
2017-08-11 2017-06-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 3,280 412 1,017
2017-05-11 2017-03-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 2,868 871 43.62 841 58.68 0.0001
2017-02-10 2016-12-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 1,997 34 1.73 530 -6.69 0.0001
2016-11-14 2016-09-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 1,963 -828 -29.67 568 -20.56 0.0001
2016-08-11 2016-06-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 2,791 -6,774 -70.82 715 -70.67 0.0001
2016-05-16 2016-03-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 9,565 7,825 449.71 2,438 313.92 0.0003
2016-02-12 2015-12-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 1,740 181 11.61 589 24.52 0.0001
2015-11-10 2015-09-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 1,559 -95 -5.74 473 -22.46 0.0001
2015-08-25 2015-06-30 13F/A-1 ISHARES TR NASDQ BIOTEC ETF 464287556 1,654 25 1.53 610 9.12 0.0001
2015-08-13 2015-06-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 1,654 610
2015-05-14 2015-03-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 1,629 -830 -33.75 559 -25.07 0.0001
2015-02-17 2014-12-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 2,459 -42 -1.68 746 9.06 0.0001
2014-11-14 2014-09-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 2,501 99 4.12 684 10.86 0.0001
2014-08-14 2014-06-30 13F ISHARES NASDQ BIOTEC ETF 464287556 2,402 -1,390 -36.66 617 -31.22 0.0001
2014-05-15 2014-03-31 13F ISHARES NASDQ BIOTEC ETF 464287556 3,792 -182,832 -97.97 897 -97.88 0.0001
2014-02-13 2013-12-31 13F ISHARES NASDQ BIOTEC ETF 464287556 186,624 38,894 26.33 42,375 36.85 0.0060
2013-11-14 2013-09-30 13F ISHARES NASDQ BIOTEC ETF 464287556 147,730 143,863 3,720.27 30,964 4,507.74 0.0047
2013-09-24 2013-06-30 13F/A-1 ISHARES TR NASDQ BIO INDX 464287556 3,867 3,867 672 0.0001
2013-08-14 2013-06-30 13F ISHARES TR NASDQ BIO INDX 464287556 3,867 672 0.0001
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2014-08-14 2014-06-30 13F ISHARES NASDQ BIOTEC ETF Put 0 -100.00 0 -100.00 n/a n/a n/a
2014-05-15 2014-03-31 13F ISHARES NASDQ BIOTEC ETF Put 5,000 -43.18 1,182 -40.84 n/a n/a n/a
2014-02-13 2013-12-31 13F ISHARES NASDQ BIOTEC ETF Put 8,800 1,998 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.